Clinical Trial Update: Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating warfarin (Coumadin) for preventing thromboembolism in atrial fibrillation patients undergoing catheter ablation. The study statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Thromboembolism

Drugs mentioned

• Coumadin (warfarin)

Snippet

Sponsor: Texas Cardiac Arrhythmia Research Foundation | Conditions: Thromboembolism | Phase 3 | Status: COMPLETED